Diagnos Inc. (V:ADK)

Business Focus: IT Services & Consulting (NEC)

Get the company report for the most recent outlook updated daily

Apr 16, 2024 11:08 am ET

DIAGNOS to expedite application for Medical Device License to Health Canada and US FDA related to its 4 new analysis modules, and is planning ISO 27001 certification

Diagnos Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a provider of healthcare services in early detection of certain critical health issues, announces today that it is working on getting new Health Canada and FDA approval on...

Apr 12, 2024 10:07 am ET

AI & Technology Hybrid Investor Conference Agenda: Presentations Now Available for Online Viewing

Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the AI & Technology Hybrid Virtual Investor Conference presented by Water Tower Research held April 10th and April 11th are now...

Apr 09, 2024 10:26 am ET

AI & Technology Hybrid Investor Conference Presented by Water Tower Research Agenda Announced for April 10 and 11

Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the AI & Technology Hybrid Investor Conference presented by Water Tower Research to be held April 10 and 11. The two-day conference...

Apr 09, 2024 10:10 am ET

DIAGNOS Inc. to Present at the AI & Technology Hybrid Investor Conference April 11th

DIAGNOS Inc. (ADK TSX: OTCQB: DGNOF), based in Montreal, Canada, focused on Artificial Intelligence for the medical market, today announced that André Larente, CEO, will present live at the AI & Technology Hybrid Virtual Investor Conference...

Apr 09, 2024 08:35 am ET

DIAGNOS inc. to Present at the AI & Technology Hybrid Investor Conference April 11th

DIAGNOS inc. (ADK TSX: OTCQB: DGNOF), based in Montreal, Canada, focused on Artificial Intelligence for the medical market, today announced that Andre Larente, CEO, will present live at the AI & Technology Hybrid Virtual Investor Conference...

Apr 03, 2024 02:13 pm ET

DIAGNOS Announces Grant of Stock Options

Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through the use of Artificial Intelligence (AI) technologies, announces today a grant of 250,000 stock options...

Apr 02, 2024 09:59 am ET

DIAGNOS Welcomes Dr. Philippe Couillard to its Board of Directors

Mar 22, 2024 04:16 pm ET

DIAGNOS Announces Closing of Second and Final Tranche of Private Placement

DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through the use of Artificial Intelligence (AI) technologies, announces the closing of a second and final...

Mar 04, 2024 03:45 pm ET

DIAGNOS Announces Grant of Stock Options

Feb 29, 2024 11:10 am ET

DIAGNOS Welcomes Mr. Michael Braeuel to its Board of Directors

Feb 27, 2024 04:13 pm ET

DIAGNOS Announces Closing of First Tranche of Private Placement

Feb 23, 2024 03:50 pm ET

Diagnos Announces Variation in One Insider Ownership of Common Shares

In accordance with regulatory requirements, Diagnos Inc. (“DIAGNOS”, the “Corporation” or the “Issuer”) (TSX Venture: ADK), announces that on February 20, 2024, Mr. Tristram Coffin (the “Investor”) disposed of 800,000 common shares (each a “Share”)...

Feb 21, 2024 09:00 am ET

DIAGNOS recognized as a Top TSX Venture Exchange Company

DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through its FLAIRE platform based on Artificial Intelligence (AI), is proud to announce that it has been...

Jan 16, 2024 10:00 am ET

DIAGNOS Appoints New Chief Operating Officer

Dec 11, 2023 09:15 am ET

DIAGNOS Secures Exclusive Distribution Agreement for Canada with EssilorLuxottica, a Global Leader in Vision Care

DIAGNOS Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through its FLAIRE platform based on Artificial Intelligence (AI), is thrilled to announce a groundbreaking...

Dec 11, 2023 08:31 am ET

Canadian Investment Regulatory Organization Trade Resumption - ADK

VANCOUVER, BC, Dec. 11, 2023 /CNW/ - Trading resumes in:

Dec 08, 2023 11:44 am ET

Canadian Investment Regulatory Organization Trading Halt - ADK

VANCOUVER, BC, Dec. 8, 2023 /CNW/ - The following issues have been halted by CIRO

Dec 04, 2023 05:00 pm ET

DIAGNOS Announces Closing of Private Placement

DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a Canadian corporation active in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces the...

Oct 05, 2023 11:08 am ET

DIAGNOS AI Retina Analysis is being deployed across Canada’s Largest Specialist Care Provider in Diabetes & Endocrinology

May 18, 2023 04:15 pm ET

DIAGNOS Announces Closing of Private Placement and Exercise of Stock Warrants

May 17, 2023 12:49 pm ET

DIAGNOS and IRIS, The Visual Group strengthen partnership with the launch of “IRIS-ai powered by DIAGNOS”

DIAGNOS Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is pleased to announce the...

Feb 28, 2023 09:00 am ET

DIAGNOS and ÉTS Unveil a Method to Adapt Deep Learning Algorithms According to the Diversity of Contexts

Diagnos Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) is one of the leaders in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI). DIAGNOS and École...

Feb 14, 2023 10:36 am ET

DIAGNOS and ETS to Present Ground-breaking Research on Mass Screening for Macular Edema at ARVO 2023

Diagnos Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) is a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI). DIAGNOS and École de...

Feb 10, 2023 03:56 pm ET

DIAGNOS Announces Grant of Stock Options

February 10, 2023 – Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces the...

Jan 31, 2023 10:04 am ET

DIAGNOS Gets the Green Light for the Use of its Diabetic Retinopathy Screening Technology in Quebec Hospitals

Diagnos Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is pleased to announce that...

Jan 13, 2023 02:12 pm ET

DIAGNOS Announces Closing of Private Placement

DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces the closing, today, of a...

Dec 15, 2022 03:00 pm ET

DIAGNOS Provides Additional Information to the Closing of Private Placement

Dec 12, 2022 02:30 pm ET

DIAGNOS Announces Closing of Private Placement

Nov 25, 2022 11:36 am ET

DIAGNOS Announces Closing of Private Placement

Oct 27, 2022 11:29 am ET

DIAGNOS Enters the Retinal Diagnostics Market With its New 3D Image Analysis Technology

Sep 01, 2022 09:30 am ET

DIAGNOS Announces Closing of Private Placement

Aug 18, 2022 12:26 pm ET

DIAGNOS Receives Regulatory Approval from the Costa Rica Health Agency for its Artificial Intelligence Enabled Pathology Detection Systems

Jul 27, 2022 09:00 am ET

DIAGNOS Continues Expansion in Canada with Kick-off of Services in Endocrinology Clinics with Distribution Partner Labtician Ophthalmics

Jun 23, 2022 09:00 am ET

DIAGNOS Announces the Start of the Deployment of its Pathology Detection Systems in the Retail Clinics of Farmacias Benavides, a Member of Walgreens Boots Alliance

Jun 07, 2022 11:44 am ET

DIAGNOS Announces the Deployment of its Age-Related Macular Degeneration Detection Application Into the Optometry Clinics of IRIS, The Visual Group

May 26, 2022 09:58 am ET

DIAGNOS and the CHUM are launching the testing phase of autonomous artificial intelligence solutions dedicated to diabetic retinopathy screening

May 10, 2022 10:32 am ET

DIAGNOS Announces a Contract with Farmacias Benavides, a Member of Walgreens Boots Alliance in Mexico

Apr 26, 2022 09:00 am ET

DIAGNOS Announces the Extension of its Contract with Novo Nordisk for the Follow-up of Diabetic Patients Under Treatment with Drugs Included in its Therapeutic Portfolio

Diagnos Inc. (“DIAGNOS”, the “Corporation” or “we”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is pleased to announce the...

Mar 28, 2022 04:15 pm ET

DIAGNOS Announces Closing of Private Placement and New Marketing Director

Mar 15, 2022 02:00 pm ET

CAN Health Network and Quebec-Based DIAGNOS Announce Life-Changing Diabetic Retinopathy Screening Program Partnership

The Coordinated Accessible National (CAN) Health Network is excited to announce that leading vision care company, DIAGNOS, is the first Quebec-based organization to join the Network. Through their strategic partner, Labtician Ophthalmics Inc, a...

Mar 01, 2022 12:54 pm ET

DIAGNOS Announces Closing of Private Placement

Feb 10, 2022 10:14 am ET

DIAGNOS Successfully Completes ISO / MDSAP Audit

Jan 26, 2022 09:00 am ET

DIAGNOS Provides Corporate Update for 2021 and Outlook for 2022

Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues based on Artificial Intelligence, is pleased to provide a corporate update on its major activities from 2021...

Dec 15, 2021 09:00 am ET

DIAGNOS will be Attending in San Francisco during the J.P. Morgan Health Care Conference Week to be held from January 10th to 13th, 2022

Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues, announces today that DIAGNOS will be in San Francisco during the J.P. Morgan 40th Annual Healthcare Conference...

Nov 23, 2021 09:00 am ET

DIAGNOS will start a clinical trial study in the USA commencing December 6th, 2021 for early detection and prevention of Stroke using CARA-STROKE.

Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues, announces today the beginning of a clinical trial study with CommonSpirit Health Research Institute, Chattanooga...

Oct 28, 2021 09:00 am ET

DIAGNOS Delivers World Class Results in the MICCAI2021 Contest: GAMMA

DIAGNOS Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of certain critical health issues, announces that its AI platform has delivered world-class results in the GAMMA (Glaucoma grAding...

Sep 24, 2021 03:00 pm ET

Diagnos Inc.: Using Artificial Intelligence to Analyze the Retina, CEO Clip Video

Vancouver, British Columbia--(Newsfile Corp. - September 24, 2021) - Diagnos Inc. (TSXV: ADK) - CEO, André Larente, speaks about their product 'Cara,' used for computer-assisted retinal analysis.

Sep 24, 2021 09:00 am ET

DIAGNOS to be Featured on CEO Clips on the BNN Bloomberg Channel

Diagnos Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of certain critical health issues, announces it will be featured on CEO Clips on the BNN Bloomberg Channel on September 25th and...

Sep 16, 2021 09:00 am ET

DIAGNOS Announces a Multi-Year Contract with Juarez Health & Medical Tourism Cluster

Diagnos Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of certain critical health issues, announces the signing of a 7-year contract with Juarez Health & Medical Tourism Cluster (“the...

Sep 14, 2021 09:00 am ET

DIAGNOS Announces a 3-Year Contract with Cielo Vista Eye Clinic in Mexico

Diagnos Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of certain critical health issues, announces the signing of a 3-year contract with Cielo Vista Eye Clinic (“Cielo”). DIAGNOS will...

Sep 10, 2021 01:34 pm ET

DIAGNOS Announces Voting Results of Annual Meeting of Shareholders

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB:DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces the voting results of its...

Sep 02, 2021 09:00 am ET

DIAGNOS Announces a Three-Year Contract Renewal with Optina Diagnostics Providing a Telemedicine Platform to Support their Early Detection of Alzheimer’s Disease Test

DIAGNOS Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of certain critical health issues, announces today a contract renewal to provide its telemedicine platform based on CARA (Computer...

Aug 17, 2021 03:30 pm ET

DIAGNOS Announces Date of Annual General and Special Meeting of Shareholders

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB:DGNOF), a leader in early detection of critical health issues, announces that the 2021 annual general and special meeting of shareholders (the “Meeting”) will be held on...

Aug 16, 2021 09:00 am ET

DIAGNOS signs Memorandum of Understanding with Essilor International.

Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of critical health issues, is pleased to announce that it has entered into a Memorandum of Understanding (MoU) with the Instruments...

Jul 28, 2021 09:05 am ET

DIAGNOS Announces a Pilot with Opticalia in Spain

Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of critical health issues, announces today the signing of a pilot in Spain with three franchisees from Opticalia Group. “A...

Jul 22, 2021 09:05 am ET

DIAGNOS Announces the Official Opening of the AI Assisted Screening Clinic at Magrabi Hospital with the Presence of the Undersecretary of the Ministry of Health of Saudi Arabia

Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of critical health issues, is pleased to announce the official opening of the initial clinics at the Magrabi Hospital. Dr. Ibrahim...

Jul 20, 2021 10:05 am ET

DIAGNOS initiates a clinical trial study in the USA for early detection and prevention of Stroke using its new application CARA-STROKE

Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues, announces today the initiation of a clinical trial study with CommonSpirit Health Research Institute, Chattanooga...

Jun 15, 2021 11:20 am ET

DIAGNOS Announces a Pilot with Hospital Oftalmológico Buena Vista Sinaloa

Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues, announces today the signing of a 2-month pilot with Hospital Oftalmológico Buena Vista Sinaloa, the largest...

Jun 09, 2021 09:12 am ET

IIROC Trading Resumption - ADK

VANCOUVER, BC, June 9, 2021 /CNW/ - Trading resumes in:

Jun 09, 2021 08:00 am ET

IRIS, a New Look Vision Group Inc. company, teams up with DIAGNOS in a multi-year agreement to implement Artificial Intelligence technology with support from the INVEST-AI Program

Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of critical health issues, is pleased to announce the signing of a multi-year agreement with IRIS The Visual Group (1990) Inc....

Jun 04, 2021 11:28 am ET

IIROC Trading Halt - ADK

VANCOUVER, BC, June 4, 2021 /CNW/ - The following issues have been halted by IIROC:

Apr 06, 2021 09:05 am ET

DIAGNOS Enters into an Exclusive Distribution Agreement to Access Massive Global Healthcare Market in DACH Countries and Central Europe of Over 140 Million People

Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today the...

Mar 09, 2021 09:05 am ET

DIAGNOS, following a successful Proof-of-Concept (POC) pilot study, is finalising its new application CARA-STROKE to address Stroke prevention and management, a market estimated at $36 Billion

Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today the final step of...

Mar 04, 2021 10:41 am ET

DIAGNOS and the third largest optical retailer in Costa Rica Piloting CARA and its Telemedicine technology

Mar 03, 2021 04:15 pm ET

DIAGNOS Announces Stock Options Grants

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces grants...

Feb 26, 2021 02:33 pm ET

DIAGNOS Announces Exercise of Stock Warrants and Provides a Cash Update

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces the exercise of 5,076,922...

Feb 24, 2021 09:30 am ET

DIAGNOS Announces its Exclusive Strategic Partnership Agreement with Labtician Ophthalmics, a Leader in Canadian and International Eyecare Markets to Address Growing Needs in the Monitoring of Diabeti

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces its exclusive strategic...

Feb 02, 2021 09:30 am ET

DIAGNOS Announces Further Deployment of its AI based CARA Technology in Saudi Arabia

Jan 28, 2021 09:30 am ET

DIAGNOS announces the re-opening of its medical testing in Panama

Jan 21, 2021 10:01 am ET

DIAGNOS Successfully Completes ISO 13485 / MDSAP Audit

Jan 19, 2021 09:30 am ET

DIAGNOS announces a 3-year partnership agreement with the University of Montreal Hospital Centre (CHUM) on the use of Artificial Intelligence

Diagnos Inc. ("DIAGNOS" or "Company") (TSX Venture Exchange: ADK) (OTCQB: DGNOF), a leader in early detection of critical health problems through the use of artificial intelligence (AI), announces a three (3) year framework partnership agreement...

Jan 14, 2021 09:30 am ET

DIAGNOS Announces Partnership in Saudi Arabia with Magrabi Hospitals and Centers to Screen Diabetic Patients

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture:ADK), (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence (AI), is pleased to announce the opening of five screening clinics at...

Jan 05, 2021 04:13 pm ET

DIAGNOS Provides Market Activity Update

Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), wishes to confirm, at the request of...

Nov 12, 2020 09:30 am ET

DIAGNOS Announces the Resumption of Screening Operations in Saudi Arabia and Conveys Congratulations to Dr. Salman Abdullah Al-Mutairi for his Assignment as Secretary General of the Council of Private

Nov 05, 2020 04:31 pm ET

9071-8776 Quebec Inc. Acquires Further Interest in DIAGNOS Inc.

In accordance with regulatory requirements, Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial...

Oct 07, 2020 04:15 pm ET

DIAGNOS Announces Stock Warrants Term Extension

Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues using advanced Artificial Intelligence (AI), announces its intention to extend the expiry date by six months of...

Oct 06, 2020 10:00 am ET

Mexico’s Largest Optical Retailer to Use DIAGNOS’ AI Technology to Detect Early Stage Blindness

Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues using advanced Artificial Intelligence (AI), announces a contract with Devlyn Grupo (“Devlyn”), an important...

Sep 28, 2020 01:11 pm ET

DIAGNOS Welcomes Mr. Vincent Duhamel and Mr. Robert J. Dunn to its Board of Directors

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is pleased to announce the...

Sep 15, 2020 10:00 am ET

DIAGNOS Announces a Multi-Year Contract with Chaparral Medical Group in California

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK, OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence (AI), announces today the signing of a three-year agreement with its US...

Sep 08, 2020 09:45 am ET

DIAGNOS Receives $2,000,000 Assistance from Quebec

Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues using advanced Artificial Intelligence (AI), is pleased to announce the signing of a financing agreement in the...

Aug 26, 2020 02:23 pm ET

DIAGNOS Announces Annual General Meeting of Shareholders Date and Attendance Special Measures

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB:DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces that the 2020 annual and...

Jul 14, 2020 09:49 am ET

DIAGNOS Announces Signing of Service Agreement with the Colombian Telemedicine Centre

Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues using advanced Artificial Intelligence (AI), is pleased to announce a service agreement with the Colombian...

Jul 07, 2020 10:41 am ET

DIAGNOS Announces that its Client in California, the Chaparral Medical Group of Clinics, is Reopening the Screening Services for Diabetic Retinopathy after the COVID-19 Shutdown

Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues using advanced Artificial Intelligence (AI), is pleased to announce that its client, Chaparral Medical Group...

Apr 27, 2020 10:04 am ET

DIAGNOS Provides Update on its CARA AI Application Participating in US White House Call to Action Data Analysis Program

DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues using advanced Artificial Intelligence (AI) tools, provides an update on its CARA (Computer Assisted Retinal...

Mar 27, 2020 03:05 pm ET

DIAGNOS Announces Stock Options Grant

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces that the board of...

Mar 25, 2020 08:45 am ET

DIAGNOS Will Utilize its Artificial Intelligence Medical Platform FLAIRE in Response to the “US White House - Call to Action” to Analyse and Transform COVID-19 Data into Clinical Knowledge

DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence (AI), announces that it is participating in the “Call to Action”...

Mar 09, 2020 04:03 pm ET

DIAGNOS Announces Closing of Oversubscribed $2.1 Million Private Placement

Feb 24, 2020 06:05 pm ET

DIAGNOS Announces Private Placement of Common Shares

Feb 14, 2020 03:30 pm ET

DIAGNOS Announces Shares for Debt Transaction

DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence (AI), announces today the issuance of 2,222,222 common shares of the...

Feb 11, 2020 05:47 pm ET

DIAGNOS Announces Closing of Private Placement

Feb 05, 2020 04:30 pm ET

DIAGNOS Announces Private Placement of Common Shares

Jan 14, 2020 09:30 am ET

DIAGNOS Successfully Completes ISO 13485 / MDSAP Surveillance Audit

Diagnos Inc. (“DIAGNOS”, the “Corporation” or ”We”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today that its...

Jan 07, 2020 09:30 am ET

DIAGNOS AI based clinical Eye Test for Diabetic Retinopathy Demonstrates Exceptional Performance at the CHUM, expands for an Additional Six Months

DIAGNOS Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture:ADK) (OTCQB:DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today the extension of its...

Dec 12, 2019 09:00 am ET

DIAGNOS Announces a New Strategic Partnership Agreement in Costa Rica

Diagnos Inc. (“DIAGNOS”, “the Corporation” or ”We”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today a new...

Dec 10, 2019 09:00 am ET

DIAGNOS Announces Collaborative Agreement in the North American Borderplex Region

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its CARA platform based on Artificial Intelligence (AI), announces today a new collaborative...

Nov 28, 2019 02:00 pm ET

DIAGNOS Welcomes Mr. Francis Bellido to its Board of Directors

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is pleased to announce the...

Nov 26, 2019 02:19 pm ET

DIAGNOS Announces Short Term Financing

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB:DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces a financing of $400,000 in...

Oct 29, 2019 09:30 am ET

DIAGNOS and its Local Partner Selected Following a Competitive Bid from the Mexican Government

Sep 25, 2019 10:09 am ET

DIAGNOS Appoints New Chairman of the Board of Directors

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is pleased to announce the...

Sep 20, 2019 11:18 am ET

DIAGNOS Announces Voting Results of Annual Meeting of Shareholders

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB:DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces the voting results of its...

Sep 16, 2019 04:00 pm ET

DIAGNOS Announces Closing of a Private Placement

DIAGNOS Inc. (“DIAGNOS”, the “Corporation” or the “Issuer”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence (AI), announces the closing of a private placement...

Sep 13, 2019 12:00 pm ET

DIAGNOS Announces Private Placement

Sep 10, 2019 09:00 am ET

DIAGNOS Receives Medical Device Marketing Authorization from the Saudi Food and Drug Authority to commercialize CARA in Saudi Arabia

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture:ADK), (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence (AI), announces today Medical Device Marketing Authorization for the...

Sep 03, 2019 11:28 am ET

DIAGNOS Announces an Extension to the Diabetic Retinopathy Screening Services Assisted by Artificial Intelligence (AI) at the CHUM

Jun 20, 2019 10:00 am ET

DIAGNOS Announces an Extension to the Diabetic Retinopathy Screening Services Assisted by Artificial Intelligence (AI) at the CHUM

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB:DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today the extension of its...

Jun 18, 2019 10:33 am ET

DIAGNOS Welcomes Mr. François Côté to its Board of Directors

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB:DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is pleased to announce the...

Jun 17, 2019 03:54 pm ET

DIAGNOS Announces Short Term Financing

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB:DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces a financing of $250,000 in...

Jun 10, 2019 10:00 am ET

DIAGNOS Announces Corporate Reorganization Update

DIAGNOS Inc. (“DIAGNOS”, “the Corporation” or “we””) (TSX Venture: ADK), (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces that it has...

Jun 06, 2019 10:00 am ET

DIAGNOS Announces HIPAA Compliance for the US market

DIAGNOS Inc. (“DIAGNOS”, “the Corporation” or “we”) (TSX Venture: ADK) (OTCQB: DGNOD), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today that its...

Jun 04, 2019 10:00 am ET

DIAGNOS Announces the Appointment of Mr. Riadh Kobbi as Vice President Business Intelligence

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK), (OTCQB: DGNOD), a leader in early detection of critical health issues through the use of Artificial Intelligence (AI), announces today the appointment of Riadh Kobbi as Vice...

May 30, 2019 10:00 am ET

DIAGNOS Announces the Opening of Two New Screening Clinics in Hafar al-Batin, to Screen 10,000 Patients in the next Six Months With its Partner Kanhoor Medical Co.

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture:ADK), (OTCQB: DGNOD), a leader in early detection of critical health issues through the use of Artificial Intelligence (AI), announces today the opening of two screening clinics in Hafar...

May 28, 2019 10:00 am ET

DIAGNOS Adds a Second Screening Site at the CHUM in the Ophthalmology Department

DIAGNOS inc. (“DIAGNOS” or the “Company”) (TSX Venture Exchange: ADK) (OTCQB: DGNOF), a leader in the early detection of serious health issues thanks to its artificial intelligence technology, FLAIRE, adds a second site to screen patients in the...

May 15, 2019 01:28 pm ET

DIAGNOS Completes Redemption of Convertible Debt

DIAGNOS Inc. (“DIAGNOS”, “the Corporation” or “we””) (TSX Venture: ADK), (OTCQB: DGNOD), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is pleased to announce that...

May 08, 2019 11:44 am ET

DIAGNOS Announces Symbol Change on the OTCQB: DGNOD

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK), (OTCQB: DGNOD), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today that further to...

May 07, 2019 10:00 am ET

DIAGNOS Announces Saudi FDA Filing for its CARA AI Platform

DIAGNOS Inc. (“DIAGNOS”, “the Corporation” or “we”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today that it has...

May 01, 2019 10:00 am ET

DIAGNOS Joins Forces with a Cannabis-Based Medicinal Products Distributor

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK), (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is pleased to announce that it has...

Apr 30, 2019 03:29 pm ET

DIAGNOS Redeems Convertible Debt

Apr 23, 2019 10:00 am ET

DIAGNOS Successfully Completes ISO 13485:2016 MDSAP Audit

Apr 16, 2019 10:00 am ET

DIAGNOS Will Supply Its Artificial Intelligence Technology to the First Hypertensive Retina Screening Clinic in Saudi Arabia.

DIAGNOS Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK), (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today it will supply its...

Apr 10, 2019 01:05 pm ET

IIROC Trading Resumption - ADK

VANCOUVER, April 10, 2019 /CNW/ - Trading resumes in:

Apr 10, 2019 01:00 pm ET

DIAGNOS Announces Approval of Corporate Reorganization

Apr 10, 2019 12:11 pm ET

IIROC Trading Halt - ADK

VANCOUVER, April 10, 2019 /CNW/ - The following issues have been halted by IIROC:

Apr 02, 2019 10:00 am ET

DIAGNOS Announces New Contract with Government in Bangladesh Through its Partner Eyes for All

Mar 27, 2019 02:51 pm ET

IIROC Trading Resumption - ADK

VANCOUVER, March 27, 2019 /CNW/ - Trading resumes in:

Mar 27, 2019 02:30 pm ET

DIAGNOS Announces an Update to the News Release Issued Earlier Today

DIAGNOS Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK), (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its proprietary FLAIRE platform based on Artificial Intelligence (AI), announces an update to...

Mar 27, 2019 11:05 am ET

IIROC Trading Halt - ADK

VANCOUVER, March 27, 2019 /CNW/ - The following issues have been halted by IIROC:

Mar 27, 2019 10:00 am ET

DIAGNOS Announces Memorandum of Understanding with one of the 5 largest hospitals in the US for the final development of its CARDIO application

Mar 13, 2019 09:44 am ET

DIAGNOS Announces New Agreement in the United Arab Emirates with one of the Largest Pharmaceutical Companies in the World

Mar 11, 2019 05:05 pm ET

DIAGNOS Announces Corporate Reorganization

Jan 29, 2019 10:43 am ET

DIAGNOS Welcomes Dr. Jean-Francois Yale to the Board of Directors

Jan 22, 2019 11:13 am ET

DIAGNOS Announces an Extension to the Diabetic Retinopathy Screening Services Assisted by Artificial Intelligence (AI) at the CHUM

DIAGNOS Inc. (“DIAGNOS” or the “Company”) (TSX Venture Exchange: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today, further to...

Dec 12, 2018 05:44 pm ET

DIAGNOS Announces Closing of Private Placement

DIAGNOS Inc. (“DIAGNOS”, the “Corporation” or the “Issuer”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence, announces the closing of a private placement (“Private...

Dec 04, 2018 09:00 am ET

DIAGNOS is announcing a collaboration with ÉTS on Automated detection and grading of Diabetic Retinopathy using Deep Convolutional Neural Networks, (CNN) a new generation of Deep Learning Technique

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture:ADK), (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence (AI), announces today a collaboration with ÉTS, École de technologie...

Nov 21, 2018 05:11 pm ET

DIAGNOS Announces Final Closing of Private Placement

DIAGNOS Inc. (“DIAGNOS”, the “Corporation” or the “Issuer”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence, announces the final closing of a private placement...

Nov 21, 2018 04:06 pm ET

DIAGNOS Enters into a Shares for Debt Transaction

DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence, announces today it has entered into a shares for debt arrangement in...

Nov 13, 2018 10:30 am ET

DIAGNOS Announces Today the Addition of a Strategic Partner in the Country of Mexico

DIAGNOS Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture:ADK), (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence (AI), announces today the addition of a strategic partner in the...

Nov 09, 2018 02:07 pm ET

DIAGNOS Announces Closing of Private Placement

DIAGNOS Inc. (“DIAGNOS”, the “Corporation” or the “Issuer”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence, announces the closing of a private placement (“Private...

Nov 06, 2018 10:08 am ET

DIAGNOS Announces Private Placement of Common Stocks and Stock Warrants

DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence, announces a private placement (“Private Placement”) of up to...

Nov 01, 2018 03:24 pm ET

DIAGNOS Announces Closing of Private Placement of Common Stocks and Stock Warrants

DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence, announces the closing of a private placement (“Private Placement”) of...

Oct 24, 2018 09:30 am ET

DIAGNOS Announces Private Placement of Common Stocks and Stock Warrants & Shares for Debt

DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence, announces a private placement (“Private Placement”) of up to...

Sep 18, 2018 09:00 am ET

DIAGNOS to Provide Retinal Image Analysis using its AI Technology to 20/20NOW, the Leading Ocular Telehealth Provider in the United States

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture:ADK), (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence (AI), announces today a three-year agreement to provide its CARA...

Sep 11, 2018 03:00 pm ET

DIAGNOS Announces Closing of Private Placement of Common Stocks and Stock Warrants

DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture:ADK) (OTCQB:DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence, announces the closing of a private placement (“Private Placement”),...

Sep 05, 2018 09:00 am ET

DIAGNOS Partners with Optina Diagnostics, a Montreal Based Company, to Provide a Web Platform for the Early Detection of Alzheimer Disease

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture:ADK), (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence (AI), announces today an agreement to provide a telemedicine platform...

Aug 24, 2018 12:24 pm ET

DIAGNOS Announces Private Placement of Common Stocks and Stock Warrants

DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture:ADK) (OTCQB:DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence, announces a private placement (“Private Placement”) of up to 1,333,333...

Jul 31, 2018 09:00 am ET

DIAGNOS Provides Update on Business Operations

Diagnos Inc. (“DIAGNOS”, “the Corporation” or “We”) (TSX Venture:ADK) (OTCQB:DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence (AI), announces today an update on business operations. We are...

Jul 10, 2018 09:00 am ET

DIAGNOS Installs its First Retina Screening Clinic based on Artificial Intelligence in Panama

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX VENTURE:ADK), (OTCQB:DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence (AI), announces today the installation of its first retina AI screening...

Jul 05, 2018 02:08 pm ET

DIAGNOS Closes Second and Final Tranche of Private Placement

DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture:ADK) (OTCQB:DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces the closing of a second and...

Jul 04, 2018 09:52 am ET

DIAGNOS Broadens its Collaboration with the Government of Mexico

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX-V:ADK), (OTCQB:DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence (AI), announces today an expansion of its screening services with the Mexican...

Jun 29, 2018 02:00 pm ET

DIAGNOS Provides Financing Updates

DIAGNOS Inc. (“DIAGNOS” or “the Corporation”) (TSX VENTURE:ADK) (OTCQB:DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), provides updates on financing...

Jun 14, 2018 02:52 pm ET

DIAGNOS Hires Investor Relation Firm Momentum Public Relations and Provides Financing Update

DIAGNOS Inc. (“DIAGNOS”, “the Corporation” or “we”) (TSX Venture:ADK) (OTCQB:DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today the signing of...

Jun 12, 2018 09:00 am ET

DIAGNOS Announces the Availability of its New CARA High Blood Pressure Risk Assessment Based on its FLAIRE Artificial Intelligence Platform

Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture:ADK) (OTCQB:DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today the availability of...

Jun 06, 2018 10:05 am ET

REMINDER: DIAGNOS presents a technological showcase at the CHUM with the opening of an automated diabetic retinopathy screening clinic assisted by AI (Artificial Intelligence) with financial support o

DIAGNOS inc. (“DIAGNOS” or the “Company”) (TSX Venture Exchange:ADK) (OTCQB:DGNOF), a leader in the early detection of serious health issues thanks to its artificial intelligence technology, FLAIRE, today announced the creation of a technological...

Jun 05, 2018 05:28 pm ET

DIAGNOS presents a technological showcase at the CHUM with the opening of an automated diabetic retinopathy screening clinic assisted by AI (Artificial Intelligence) with financial support of the Québ

DIAGNOS inc. (“DIAGNOS” or the “Company”) (TSX Venture Exchange:ADK) (OTCQB:DGNOF), a leader in the early detection of serious health issues thanks to its artificial intelligence technology, FLAIRE, today announced the creation of a technological...

May 28, 2018 03:25 pm ET

DIAGNOS Announces Private Placement and Stock Options Grant

DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture:ADK) (OTCQB:DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence, announces a private placement (“Private Placement”) of up to 24 units...

Apr 06, 2018 03:30 pm ET

DIAGNOS Sells 10,500,000 Common Shares of Albert Mining Inc.

BROSSARD, Quebec, April 06, 2018 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or “the Corporation”) (TSX VENTURE:ADK) (OTCQB:DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces...

Apr 04, 2018 11:00 am ET

DIAGNOS Welcomes Dr. Reid Maclellan to the Board of Directors

BROSSARD, Quebec, April 04, 2018 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture:ADK) (OTCQB:DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI),...

Mar 14, 2018 10:00 am ET

DIAGNOS Announces the Opening of a Screening Clinic at Chaparral’s Health Management Wellness Center for Medicare Beneficiaries

BROSSARD, Quebec, March 14, 2018 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture:ADK) (OTCQB:DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI),...

Mar 07, 2018 10:05 am ET

Following a successful year, DIAGNOS Announces a One-Year Agreement in United Arabs Emirates with a Major Pharmaceutical Company

BROSSARD, Quebec, March 07, 2018 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or “the Corporation”) (TSX-V:ADK) (OTCQB:DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces...

Feb 27, 2018 03:49 pm ET

After Successful Screening of 2,500 patients as part of a Pilot Project with Kanhoor Medical Co, DIAGNOS will Now Screen 35,000 patients in the Kingdom of Saudi Arabia

BROSSARD, Québec, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture:ADK), (OTCQB:DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI),...

Feb 14, 2018 10:12 am ET

DIAGNOS Provides a Market Update on Recent Trading

BROSSARD, Quebec, Feb. 14, 2018 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS”, “the Corporation” or “we”) (TSX Venture:ADK) (OTCQB:DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence...

Jan 25, 2018 03:13 pm ET

Arrowhead Business and Investment Decisions Initiates Analyst Coverage of DIAGNOS

BROSSARD, Quebec, Jan. 25, 2018 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS”, “the Corporation” or “we”) (TSX VENTURE:ADK) (OTCQB:DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence...

Jan 17, 2018 09:00 am ET

DIAGNOS Announces that the Next Release of its CARA Artificial Intelligence Platform Will Rely on Blockchain Technology for Security Control of Medical Records

BROSSARD, Quebec, Jan. 17, 2018 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS”, “the Corporation” or “we”) (TSX VENTURE:ADK) (OTCQB:DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence...

Jan 10, 2018 11:06 am ET

DIAGNOS Announces the Management of the Flagship Nuevo Yo Program by Novo Nordisk

BROSSARD, Quebec, Jan. 10, 2018 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS”, “the Corporation” or “we”) (TSX VENTURE:ADK) (OTCQB:DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence...

Dec 19, 2017 09:00 am ET

DIAGNOS Successfully Passed ISO Annual Surveillance Audit

DIAGNOS Inc. ("DIAGNOS", "the Corporation" or "we") (TSX VENTURE: ADK)(OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today that it has successfully passed the ISO 13485 - Medical devices and ISO 9001 annual surveillance audit for its CARA healthcare platform.

Dec 19, 2017 08:58 am ET

DIAGNOS Successfully Passed ISO Annual Surveillance Audit

Dec 06, 2017 09:00 am ET

DIAGNOS Receives Support from Export Development Canada (EDC) for the Issuance of a Performance Bond for the ISSSTE Contract

DIAGNOS Inc. ("DIAGNOS", "the Corporation" or "we") (TSX VENTURE: ADK)(OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today that EDC has agreed to act as guarantor in connection with issuance of a performance bond under the terms of the agreement with ISSSTE, initially announced on July 17th of this year.

Dec 06, 2017 08:58 am ET

DIAGNOS Receives Support from Export Development Canada (EDC) for the Issuance of a Performance Bond for the ISSSTE Contract

Nov 29, 2017 09:00 am ET

DIAGNOS Hires Investor Relation Firm Arrowhead Business and Investment Decisions, LLC and Grants Stock Options

DIAGNOS Inc. ("DIAGNOS", "the Corporation" or "we") (TSX VENTURE: ADK)(OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today the signing of an agreement with Arrowhead Business and Investment Decisions LLC ("Arrowhead") of New York, NY, with the main objective of raising DIAGNOS profile among targeted U.S. institutional and private investors, and a stock options grant to one Director.

Nov 29, 2017 08:58 am ET

DIAGNOS Hires Investor Relation Firm Arrowhead Business and Investment Decisions, LLC and Grants Stock Options

Nov 22, 2017 01:21 pm ET

DIAGNOS Announces a Second Contract for Its Cardio Platform with a Multinational Pharmaceutical Company and the Resignation of a Director

DIAGNOS Inc. ("DIAGNOS", "the Corporation" or "we") (TSX VENTURE: ADK)(OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today a second Cardio project with one of the largest pharmaceutical company in the world to monitor hypertensive patients under treatment and the resignation of Dr. Netan Choudhry, Director since 2016.

Nov 22, 2017 01:21 pm ET

DIAGNOS Announces a Second Contract for Its Cardio Platform with a Multinational Pharmaceutical Company and the Resignation of a Director

Nov 09, 2017 02:00 pm ET

DIAGNOS Announces New Project with Cardiology Department of the Centre National de Medecine du Sport C.N.M.S Hospital located in Alger, Algeria, before product launch

DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK)(OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI ), announces today a project in alliance with Dr Abdelbaki Mourad Cardiologist at Cardiology department of the Centre National de Medecine du Sport "C.N.M.S - Hospital" Alger, Algeria to monitor 1000 patients with coronary heart disease condition.

Nov 09, 2017 01:58 pm ET

DIAGNOS Announces New Project with Cardiology Department of the Centre National de Medecine du Sport C.N.M.S Hospital located in Alger, Algeria, before product launch

Oct 24, 2017 09:00 am ET

DIAGNOS Announces a One-Year Agreement in North Africa with a Major Pharmaceutical Company after Successful Pilot

DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK)(OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today a positive conclusion to a pilot project by signing a turnkey one-year screening contract in North Africa.

Oct 24, 2017 08:58 am ET

DIAGNOS Announces a One-Year Agreement in North Africa with a Major Pharmaceutical Company after Successful Pilot

Oct 23, 2017 03:43 pm ET

DIAGNOS Closes Second Tranche of Private Placement

DIAGNOS Inc. ("DIAGNOS" or the "Corporation") (TSX VENTURE: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence, announces the closing of a second tranche of 2 units (each a "Unit"), for gross cash receipts of $100,000, as part of a private placement ("Private Placement") initially announced on October 16, 2017. The aggregate cash receipts from the Private Placement amount to $1,000,000. Each Unit consists of:

Oct 23, 2017 03:43 pm ET

DIAGNOS Closes Second Tranche of Private Placement

Oct 17, 2017 09:00 am ET

DIAGNOS Announces a New Partner in Cambodia, Garuda Health Services

DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK)(OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today the addition of a new partner to cover Cambodia, Garuda Health Services. Cambodia is the 16th country in the world where we will be able screen patients.

Oct 17, 2017 08:58 am ET

DIAGNOS Announces a New Partner in Cambodia, Garuda Health Services

Oct 16, 2017 03:08 pm ET

DIAGNOS Announces Closing of a Private Placement

Oct 16, 2017 03:08 pm ET

DIAGNOS Announces Closing of a Private Placement

DIAGNOS Inc. ("DIAGNOS" or the "Corporation") (TSX VENTURE: ADK)(OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence, announces closing of a private placement ("Private Placement"), as of October 13, 2017, of 18 units (each a "Unit") for gross cash proceeds of $900,000. Each Unit consists of:

Sep 26, 2017 09:00 am ET

DIAGNOS Announces DTC Eligibility of its Common Shares in the US

DIAGNOS Inc. ("DIAGNOS" or the "Corporation") (TSX VENTURE: ADK)(OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence, is pleased to announce that the Corporation's common shares traded on the OTC Markets Group Inc.'s OTCQB Venture Market in the United States, under the symbol "DGNOF", are Depository Trust Company ("DTC") eligible, effective September 22, 2017. DTC is a subsidiary of the Depository Trust & Clearing Corp. and manages the electronic clearing and settlement of share

Sep 26, 2017 08:58 am ET

DIAGNOS Announces DTC Eligibility of its Common Shares in the US

Sep 19, 2017 09:00 am ET

DIAGNOS Provides Timelines on Cardiovascular Disease (CVD) Prevention Test Development and Commercialization Plans

DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK)(OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today a development of new cardiovascular risk score, that will enable the early detection of this critical disease by its CARA platform.

Sep 19, 2017 08:58 am ET

DIAGNOS Provides Timelines on Cardiovascular Disease (CVD) Prevention Test Development and Commercialization Plans

Aug 28, 2017 03:34 pm ET

DIAGNOS Announces Restatement of March 31, 2017 Financial Statements which Resulted in a Decrease in Expenses of $2,491,096

Aug 28, 2017 03:33 pm ET

DIAGNOS Announces Restatement of March 31, 2017 Financial Statements which Resulted in a Decrease in Expenses of $2,491,096

DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK)(OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today the refiling of the March 31, 2017 annual filings comprised of the restated March 31, 2017 annual financial statements and the restated annual Management Discussion and Analysis as well as the restated 2017 annual report.

Aug 22, 2017 10:00 am ET

DIAGNOS Announces 2 screening clinics with Al Kahhal Medical Complex in the Kingdom of Saudi Arabia

DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK)(OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today the implementation of DIAGNOS CARA (Computer Assisted Retina Analysis) telemedicine platform at Al Kahhal Medical Complex clinic. With our Saudi Arabia business partner, Al Kanhoor Medical Co, we will make retinal screening exams available to the diabetic population in the cities of Dammam and AL-Hasha Eastern Province of Saudi Arabia. As per the

Aug 22, 2017 09:58 am ET

DIAGNOS Announces 2 screening clinics with Al Kahhal Medical Complex in the Kingdom of Saudi Arabia

Aug 14, 2017 11:25 am ET

DIAGNOS Announces Results from the Annual Meeting of Shareholders, Appointments of new Chairman and new Chief Medical Officer and Stock Options Grant

Aug 14, 2017 11:25 am ET

DIAGNOS Announces Results from the Annual Meeting of Shareholders, Appointments of new Chairman and new Chief Medical Officer and Stock Options Grant

DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK)(OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today results from the votes at the annual general meeting of shareholders ("AGM") held on July 21, 2017, the appointments of Mr. Georges Hebert as Chairman of the board of directors and Dr. Hadi Chakor as Chief Medical Officer and stock options grants to directors and officers.

Jul 17, 2017 10:32 am ET

DIAGNOS signs new contract valued at $ 4.16 Million USD (5.26 Million CAD) with the Government of Mexico at ISSSTE to screen and monitor 320,000 diabetics in 2017 further to a successful...

DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK)(OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today the signature of a new contract valued at $ 4.16 Million USD (5.26 Million CAD). This contract was awarded after the completion of a successful pilot program covering 79,407 patients.

Jul 17, 2017 10:32 am ET

DIAGNOS signs new contract valued at $ 4.16 Million USD (5.26 Million CAD) with the Government of Mexico at ISSSTE to screen and monitor 320,000 diabetics in 2017 further to a successful...

Jul 14, 2017 10:41 am ET

IIROC Trading Halt - ADK

VANCOUVER, July 14, 2017 /CNW/ - The following issues have been halted by IIROC:

Jul 05, 2017 08:58 am ET

DIAGNOS Announces Successful Pilot at Chaparral Medical Group in California and a 3 Year Contract with the Opening of a Second Eye Screening Clinic

Diagnos Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK)(OTCQB:DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence, announces today the signing of a three year agreement with Chaparral...

Jun 27, 2017 11:56 am ET

DIAGNOS Receives Approval for Trading on the OTCQB Venture Market

Jun 27, 2017 11:56 am ET

DIAGNOS Receives Approval for Trading on the OTCQB Venture Market

DIAGNOS Inc. ("DIAGNOS" or the "Corporation") (TSX VENTURE: ADK)(OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence, is pleased to announce that the Corporation's common shares now trade on the OTCQB Venture Market, under the symbol "DGNOF." DIAGNOS continues to trade on the TSX Venture Exchange under its existing "ADK" symbol.

Jun 12, 2017 04:23 pm ET

DIAGNOS Announces Amendment to its Stock Option Plan

DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in early detection of critical health issues through the use of Artificial Intelligence, announces that the board of directors of the Corporation has approved an amendment to the Corporation's Stock Option Plan ("Plan") in order to set the vesting from three (3) years to two (2) years, the first half (50%) number of options being exercisable on the first anniversary of the grant date and the full (100%) number of options being exercisable on the second anniversary of the grant. This

Jun 12, 2017 04:23 pm ET

DIAGNOS Announces Amendment to its Stock Option Plan

May 31, 2017 01:00 pm ET

DIAGNOS Announces its New Mission in Healthcare after its Divestiture from the Mining Industry

Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX VENTURE:ADK), a leader in early detection of critical health issues through the use of Artificial Intelligence, announces its new mission in healthcare. Further to the news release dated...

Ad blocking detected

Diagnos Inc. (V:ADK)

Business Focus: IT Services & Consulting (NEC)